Neuroprotective effects of dexmedetomidine combined with goal-directed haemodynamic therapy for patients undergoing cranial surgery
- PMID: 36479989
- DOI: 10.1097/EJA.0000000000001714
Neuroprotective effects of dexmedetomidine combined with goal-directed haemodynamic therapy for patients undergoing cranial surgery
Comment in
-
Reply to: neuroprotective effects of dexmedetomidine combined with GDHT for patients undergoing cranial surgery.Eur J Anaesthesiol. 2023 Jan 1;40(1):63-64. doi: 10.1097/EJA.0000000000001708. Eur J Anaesthesiol. 2023. PMID: 36479990 No abstract available.
Comment on
-
Neuroprotective effects of intraoperative dexmedetomidine versus saline infusion combined with goal-directed haemodynamic therapy for patients undergoing cranial surgery: A randomised controlled trial.Eur J Anaesthesiol. 2021 Dec 1;38(12):1262-1271. doi: 10.1097/EJA.0000000000001532. Eur J Anaesthesiol. 2021. PMID: 34101714 Clinical Trial.
References
-
- Chen PH, Tsuang FY, Lee CT, et al. Neuroprotective effects of intraoperative dexmedetomidine infusion combined with goal-directed hemodynamic therapy for patients undergoing cranial surgery: a double-blinded randomized controlled trial. Eur J Anaesthesiol 2021; 38:1262–1271.
-
- Su X, Meng ZT, Wu XH, et al. Dexmedetomidine for prevention of delirium in elderly patients after noncardiac surgery: a randomised, double-blind, placebo-controlled trial. Lancet 2016; 388:1893–1902.
-
- Liu C, Zhang Y, She S, et al. A randomised controlled trial of dexmedetomidine for suspension laryngoscopy. Anaesthesia 2013; 68:60–66.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
